Baclosign: Targeted Muscle Spasticity Relief for Enhanced Mobility
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.23 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $85.85 $71.29 (17%) | 🛒 Add to cart |
| 120 | $0.73 | $114.47 $87.36 (24%) | 🛒 Add to cart |
| 180 | $0.69 | $171.70 $123.50 (28%) | 🛒 Add to cart |
| 270 | $0.66 | $257.55 $178.73 (31%) | 🛒 Add to cart |
| 360 | $0.62
Best per pill | $343.40 $223.91 (35%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.52 | $45.18 $45.18 (0%) | 🛒 Add to cart |
| 20 | $3.97 | $90.37 $79.32 (12%) | 🛒 Add to cart |
| 30 | $3.18 | $135.55 $95.39 (30%) | 🛒 Add to cart |
| 60 | $3.03 | $271.10 $181.74 (33%) | 🛒 Add to cart |
| 90 | $2.86 | $406.65 $257.05 (37%) | 🛒 Add to cart |
| 120 | $2.70 | $542.21 $324.32 (40%) | 🛒 Add to cart |
| 180 | $2.49 | $813.31 $448.83 (45%) | 🛒 Add to cart |
| 270 | $2.34 | $1219.96 $631.57 (48%) | 🛒 Add to cart |
| 360 | $2.24
Best per pill | $1626.62 $806.28 (50%) | 🛒 Add to cart |
Baclosign (baclofen) is a centrally acting skeletal muscle relaxant specifically formulated to manage spasticity resulting from multiple sclerosis, spinal cord injuries, and related neurological disorders. By acting on GABA-B receptors in the spinal cord, it reduces the frequency and amplitude of muscle spasms, enabling improved voluntary motor control and daily functioning. This agent is recognized for its efficacy in alleviating discomfort, enhancing range of motion, and supporting rehabilitation efforts. Proper administration under medical supervision ensures optimal therapeutic outcomes while minimizing risks.
Features
- Active ingredient: Baclofen
- Available in 10 mg and 25 mg tablet strengths
- Mechanism: GABA-B receptor agonist in the spinal cord
- Prescription-only medication
- Manufactured under strict pharmaceutical compliance (GMP)
- White, round, scored tablets for accurate dosing
Benefits
- Reduces muscle spasticity and associated pain, improving comfort during rest and activity.
- Enhances functional mobility, facilitating participation in physical therapy and daily tasks.
- Decreases muscle rigidity, allowing for greater range of motion and ease of movement.
- Supports long-term management of chronic spasticity with a well-established safety profile.
- May improve sleep quality by reducing nighttime spasms and discomfort.
- Contributes to overall quality of life by enabling greater independence and reduced caregiver burden.
Common use
Baclosign is primarily indicated for the management of spasticity in patients with conditions such as multiple sclerosis, spinal cord lesions, and other spinal cord diseases. It is used to alleviate symptoms including muscle stiffness, involuntary contractions, and pain, thereby supporting physical rehabilitation and improving functional capacity. It may also be prescribed off-label for certain cases of intractable hiccups or trigeminal neuralgia under specialist guidance.
Dosage and direction
Dosage must be individualized based on patient response and tolerance. The initial dose for adults is typically 5 mg administered orally three times daily. This may be increased gradually by 5 mg every three days until the desired effect is achieved. The maximum recommended daily dose is 80 mg (20 mg four times daily). Tablets should be taken with water, with or without food. Abrupt discontinuation should be avoided; taper dosage gradually under medical supervision to prevent withdrawal symptoms.
Precautions
- Use with caution in patients with a history of seizure disorders, psychiatric conditions, stroke, or renal impairment.
- May cause drowsiness or dizziness; patients should avoid driving or operating machinery until they know how the medication affects them.
- Elderly patients may be more sensitive to side effects; lower doses may be advisable.
- Not recommended during pregnancy unless clearly needed; discuss risks and benefits with a healthcare provider.
- Alcohol and other CNS depressants may enhance sedative effects.
Contraindications
- Hypersensitivity to baclofen or any component of the formulation.
- Patients with a history of peptic ulcer disease or gastrointestinal bleeding (relative contraindication).
- Severe renal impairment or end-stage renal disease requiring dialysis.
- Concurrent use with other central nervous system depressants in uncontrolled settings.
Possible side effects
Common side effects may include:
- Drowsiness
- Dizziness
- Weakness or fatigue
- Nausea
- Headache
- Insomnia
Less common but serious side effects require immediate medical attention:
- Hallucinations or confusion
- Severe muscle weakness
- Mood changes or depression
- Seizures
- Signs of allergic reaction (rash, itching, swelling)
Drug interaction
- CNS depressants (e.g., alcohol, benzodiazepines, opioids): increased sedation and respiratory depression.
- Antihypertensives: may potentiate blood pressure-lowering effects.
- MAO inhibitors: risk of increased CNS depression.
- Tricyclic antidepressants: may enhance muscle relaxant effects.
- Levodopa: may exacerbate psychiatric symptoms.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to catch up. Resume the regular dosing schedule. Consult a healthcare provider if multiple doses are missed or if uncertainty exists regarding administration.
Overdose
Symptoms of overdose may include vomiting, muscle weakness, drowsiness, dilated pupils, respiratory depression, seizures, or coma. Seek immediate medical attention. Treatment is supportive and may include gastric lavage, activated charcoal, and management of symptoms. There is no specific antidote.
Storage
Store at room temperature (15–30°C) in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized guidance. Do not initiate, adjust, or discontinue medication without medical supervision.
Reviews
“After three months on Baclosign, my muscle tightness has decreased significantly. I can now participate in physiotherapy with much less pain.” – Maria K., 54
“Effective for spasticity management, though the drowsiness was noticeable initially. Titrating slowly helped mitigate this.” – James L., 61
“As a neurologist, I find Baclosign to be a reliable option for patients with MS-related spasticity. Patient response is generally positive with careful dosing.” – Dr. A. Reynolds, MD